When the Publishers Won’t Play Ball
Médecins Sans Frontières (MSF) have raised an issue of great concern in Sub-Saharan Africa. The most effective anti-venom used there to treat cases of snakebite, Fav-Afrique , is no longer being produced by the manufacturer, French pharmaceutical company Sanofi. The existing batches will run out in 2016. Even if another company took up production, it would be two years before replacements would be available. The company says it is no longer profitable to make the drug.
Why am I writing about this in a law blog? In a way it follows on from my previous blog which outlined my case . . . [more]


